Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia M Beasley

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanomaRyan S Turley, Andrew N Fontanella, James C Padussis, et al.
Cell Reports|May 5, 2021
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapyNicholas C DeVito, Michael Sturdivant, Balamayooran Thievanthiran, et al.
Journal of Surgical Oncology|September 17, 2022
Regional control after precision lymph node dissection for clinically evident melanoma metastasisKevin T Lynch, Yinin Hu, Norma E Farrow, et al.
Surgical Oncology|November 8, 2020
The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanomaSurya Ravichandran, Neel Nath, David C Jones, et al.
Journal for Immunotherapy of Cancer|April 20, 2021
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanomaGeorgia M Beasley, Smita K Nair, Norma E Farrow, et al.
Annals of Surgery|March 21, 2014
Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanomaRyan S Turley, Yoshihiro Tokuhisa, Hiroaki Toshimitsu, et al.
Annals of Surgical Oncology|May 17, 2017
Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter StudyGeorgia M Beasley, Yinin Hu, Linda Youngwirth, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2020
Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detectionGeorgia M Beasley, Aaron D Therien, Eda K Holl, et al.
Frontiers in Immunology|August 14, 2023
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasmsAustin M Eckhoff, Michael C Brown, Karenia Landa, et al.
Science Translational Medicine|November 23, 2022
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapyBalamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanomaRyan S Turley, Andrew N Fontanella, James C Padussis, et al.
Cell Reports|May 5, 2021
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapyNicholas C DeVito, Michael Sturdivant, Balamayooran Thievanthiran, et al.
Journal of Surgical Oncology|September 17, 2022
Regional control after precision lymph node dissection for clinically evident melanoma metastasisKevin T Lynch, Yinin Hu, Norma E Farrow, et al.
Surgical Oncology|November 8, 2020
The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanomaSurya Ravichandran, Neel Nath, David C Jones, et al.
Journal for Immunotherapy of Cancer|April 20, 2021
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanomaGeorgia M Beasley, Smita K Nair, Norma E Farrow, et al.
Annals of Surgery|March 21, 2014
Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanomaRyan S Turley, Yoshihiro Tokuhisa, Hiroaki Toshimitsu, et al.
Annals of Surgical Oncology|May 17, 2017
Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter StudyGeorgia M Beasley, Yinin Hu, Linda Youngwirth, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2020
Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detectionGeorgia M Beasley, Aaron D Therien, Eda K Holl, et al.
Frontiers in Immunology|August 14, 2023
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasmsAustin M Eckhoff, Michael C Brown, Karenia Landa, et al.
Science Translational Medicine|November 23, 2022
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapyBalamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, et al.
Pageof 13